NEO
NeoGenomics, Inc.
Stock
$18.47+0.69 (+3.88%)Close Oct 2, 2026
- Capital expenditures, 2025
- $27M
- YoY, 2025
- −34.2%
- 5-year CAGR
- −1.5%
- 10-year CAGR
- +28.4%
Capital expenditures
Capital expenditures by fiscal year
| Period | Capex | YoY |
|---|---|---|
| 2025 | $27M | −34.2% |
| 2024 | $41M | +42.8% |
| 2023 | $29M | −6.9% |
| 2022 | $31M | −51.8% |
| 2021 | $64M | +120.4% |
| 2020 | $29M | +45.3% |
| 2019 | $20M | +40.0% |
| 2018 | $14M | +4.5% |
| 2017 | $14M | +81.7% |
| 2016 | $7.5M | +240.2% |
| 2015 | $2.2M | −41.3% |
| 2014 | $3.8M | +87.6% |
| 2013 | $2.0M | −23.1% |
| 2012 | $2.6M | +191.5% |
| 2011 | $897K | −2.1% |
| 2010 | $916K | — |